"The U.S. Food and Drug Administration today approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin infections.
Orbactiv is approved to treat patients with acute bacterial skin and skin structure infections (ABSS"...
Kuric™ is contraindicated in persons who have shown hypersensitivity to the active or excipient ingredients of this formulation.
Last reviewed on RxList: 8/23/2011
This monograph has been modified to include the generic and brand name in many instances.
Additional Kuric Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.